Avidity Partners Management LP Athira Pharma, Inc. Transaction History

Avidity Partners Management LP

  • $370 Million
  • Q2 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$10.24 - $20.87 $17.2 Million - $35 Million
-1,677,845 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$16.9 - $29.77 $10.7 Million - $18.9 Million
633,972 Added 60.73%
1,677,845 $30.9 Million
Q4 2020

Feb 16, 2021
BUY
$16.48 - $34.3 $288,910 - $601,313
17,531 Added 1.71%
1,043,873 $35.8 Million
Q3 2020

Nov 16, 2020
BUY
$16.02 - $18.46 $16.4 Million - $18.9 Million
1,026,342 New
1,026,342 $18.9 Million

Others Institutions Holding ATHA

# of Institutions
58
Shares Held
18.5M
Call Options Held
24.1K
Put Options Held
0
View Full List

About Athira Pharma, Inc.

ATHA Quotes by TradingView
  • Ticker ATHA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,817,700
  • Market Cap $156M
  • Description
  • Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...
More about ATHA
Track This Portfolio

Track Avidity Partners Management LP Portfolio

Follow Avidity Partners Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Avidity Partners Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email